Skip to main content
FERMENTA BIOTECH LIMITED logo

FERMENTA BIOTECH LIMITED — Investor Relations & Filings

Ticker · FERMENTA ISIN · INE225B01021 LEI · 335800VNTNWW8G1U9314 BSE.NS Manufacturing
Open in API
Filings indexed 671 across all filing types
Latest filing 2023-12-07 Regulatory Filings
Country IN India
Listing BSE.NS FERMENTA

About FERMENTA BIOTECH LIMITED

https://fermentabiotech.com

Fermenta Biotech Limited is a specialized biotechnology company primarily focused on the development and manufacture of Vitamin D3 (Cholecalciferol). As one of the few vertically integrated manufacturers globally, the company produces Vitamin D3 for diverse applications, including pharmaceuticals, dietary supplements, human nutrition, and animal feed. Beyond its core Vitamin D3 portfolio, the company offers a range of specialty enzymes, particularly for the synthesis of beta-lactam antibiotics, and provides environmental solutions through its biotechnology expertise. Fermenta Biotech emphasizes high-quality standards, maintaining various international certifications for its manufacturing facilities. Its product offerings extend to premixes and value-added formats designed to meet specific formulation requirements. The company serves a global clientele, leveraging its research and development capabilities to innovate in the fields of nutrition and biotechnology.

Recent filings

Filing Released Lang Actions
Loss of Share Certificate
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to the stock exchange (BSE Limited) regarding the loss of share certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to the reporting of lost or stolen share certificates. The content is an intimation or notification about a specific event related to share certificates, not a financial report, management change, or other types of filings. The document length is short (1288 characters) and it serves as an official notification to the exchange for record-keeping purposes. This fits the category of Regulatory Filings (RNS), which is a fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-12-07 English
Execution of Sale Deed
Capital/Financing Update Classification · 95% confidence The document is an official communication addressed to the stock exchange (BSE Limited) regarding the execution of a sale deed for a substantial portion of the company's land. It references a prior intimation about members' approval for asset disposal and provides detailed information about the sale transaction, including parties involved, terms, and consideration amount. The document is an announcement of a significant transaction related to the company's assets, filed under SEBI regulations. It does not contain financial statements, audit information, or detailed financial performance data. It is not a report or presentation but an update on a capital asset sale. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is 3709 characters, which is consistent with a detailed announcement rather than a full report.
2023-12-04 English
Further to our intimation dated November 08, 2023 regarding approval of unaudited financial results (standalone and consolidated) by the Board of Directors for the quarter and half year ....
Investor Presentation Classification · 95% confidence The document is titled 'Earnings Presentation for Quarter 2 – Financial Year 2023-2024' and contains detailed financial data including quarterly and half-yearly standalone and consolidated financial performance, revenue mix, operational highlights, and historical financial statements. It is an earnings presentation document, as explicitly stated in the subject line and throughout the text. The document is about 15,000 characters long and contains substantive financial data and analysis, not just an announcement or a brief summary. Therefore, it fits the category of an Investor Presentation (IP) rather than a simple Earnings Release (ER) which typically contains only key highlights. The presence of detailed charts, operational highlights, and financial metrics supports classification as an Investor Presentation.
2023-11-28 English
Further to our intimation dated November 08, 2023 regarding approval of Unaudited financial results (Standalone and Consolidated) by the Board of Directors for the quarter and half year ....
Earnings Release Classification · 95% confidence The document is titled 'Earnings Presentation for Quarter 2 – Financial Year 2023-2024' and contains detailed financial data including quarterly and half-yearly standalone and consolidated financial performance, operational highlights, revenue mix, and historical financial statements. It is an earnings presentation document, not just an announcement or a brief summary. The length is substantial (15,000 characters), and it includes financial metrics such as revenue, EBITDA, PAT, EPS, and operational details. There is no indication that this is a full annual report or an interim report with full financial statements, but rather a presentation focused on quarterly earnings results. Therefore, the document fits the category of an Earnings Release (ER) type, specifically an earnings presentation for Q2 FY24. Q2 2024
2023-11-28 English
Revision in credit rating
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) informing about a revision in the company's credit rating by CARE Ratings Limited. It references SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events. The content focuses on credit rating changes and the reasons behind the downgrade, including financial performance deterioration. The document is an update on financing conditions rather than a full financial report or earnings release. It is also relatively short (2419 characters) and serves as an official announcement of a credit rating update. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2023-11-16 English
Loss of share certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the stock exchange (BSE Limited) under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the loss of share certificates by a shareholder. The content is an official notification related to shareholding records and compliance with listing regulations. It is not a financial report, earnings release, management discussion, or any form of annual or interim report. It is also not a voting result, capital change, or director dealing. The document is a regulatory announcement informing the exchange and public about a specific event concerning share certificates. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-11-11 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.